KLAS Drives Enterprise Procurement Decisions

KLAS matters because it shrinks a risky hospital software search into a short list that already carries peer validation. In practice, health system buyers often start with vendors that KLAS has already field checked with provider references, then spend procurement time on security, workflow fit, and EHR integration. For Abridge, winning Best in KLAS in February 2026 reinforces its position as the safe choice for large systems already standardizing around Epic and other major EHRs.1 2 3 4 5

• Hospital buying is top down, not doctor by doctor. In AI scribes, local clinician preference can be overridden by enterprise leadership, especially once IT, compliance, and business associate agreements are involved. That makes an external ranking system more valuable as a screening tool for executives who are far from day to day product use.2 3
• Abridge pairs that third party proof point with distribution through major records systems. It partnered with Epic in August 2023 and athenahealth in February 2025, and grew from about 8,000 to more than 60,000 clinicians across 100 plus health systems in 18 months. KLAS helps the shortlist, while EHR partnerships help the close.3 4 5
• This is especially important in a crowded category. AI medical scribes pulled in about $800M of VC funding in 2024, and competitors range from enterprise vendors like Ambience to bottom up products like Freed. In that market, repeat KLAS recognition gives procurement teams a simple reason to prefer the incumbent looking option over a newer entrant.3 6

The next step is that KLAS shifts from helping Abridge win ambient note deals to helping it expand into adjacent hospital workflows like nursing, coding, and revenue cycle. If Abridge keeps pairing strong KLAS performance with deep EHR integrations, it can become the default add on for documentation and downstream financial workflows inside major health systems.3 5 7